Home › Respiratory Failure › NCT04626154
Thoracoabdominal Asynchrony and Respiratory Distress
Validation of a Non-Invasive Device for Thoracoabdominal Asynchrony-Based Respiratory Effort Assessment in Pediatric Patients
Who can join
28 Days – 17 Years · All sexes
Full eligibility criteria
Inclusion Criteria: 1. patients 28-days to 17-years of age 2. who have respiratory distress and those who do not have respiratory distress Exclusion Criteria: Hardware, clinical care, or dermal injury that would preclude the application of TAA device
About the study
The investigators hypothesize that a simple 3-point tracking device that uses motion sensors attached to the abdomen and chest of a child will provide information regarding thoracoabdominal asynchrony (TAA), a major component of respiratory distress, and ultimately help guide a clinician to initiate, escalate, de-escalate, or stop respiratory support interventions.
AIMS To determine if the TAA-monitoring device can be used to detect differences in respiratory synchrony in a manner that is clinically applicable. The investigators hope that the device will detect 1) major asynchrony events in a timely manner so as to prompt clinician intervention during future use; and 2) asynchrony events that may be less visible to the naked eye that may be precursors to more severe events.
What is being tested
- Objectively monitoring thoracoabdominal asynchrony (diagnostic test)
Sponsor: Massachusetts General Hospital · Participants: 20 · Started: Oct 16, 2020
Contact the study team
- Ryan Carroll, MD, MPH · Phone: 7733328178
Official record on ClinicalTrials.gov — NCT04626154
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.